Skip to main content
All lobbying filings

W STRATEGIES, LLC

Lobbying for GILEAD SCIENCES, INC. · American biotechnology company that researches, develops and commercializes drugs.

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 1
  • HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 1
  • HR 5376
    Impacts and Outcomes for Health Career Training Act
 Lobbying activity 2
Medicare/Medicaid

Implementation H.R.5376 - Inflation Reduction Act of 2022. Public Law 119-21: One Big Beautiful Bill Act.

Health Issues

Education about access to HIV medicines. Education about the 340(b) program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem